Effect of thyroid funtion and of obesity on discriminant function for mammary carcinoma.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000368:Aged; D000728:Androgens / Q000652:urine*; D000738:Androsterone / Q000652:urine; D001943:Breast Neoplasms / Q000150:complications / Q000601:surgery / Q000652:urine*; D003687:Dehydroepiandrosterone / Q000652:urine; D005043:Etiocholanolone / Q000652:urine; D005260:Female; D005938:Glucocorticoids / Q000652:urine*; D006801:Humans; D006980:Hyperthyroidism / Q000652:urine; D007037:Hypothyroidism / Q000652:urine; D008875:Middle Aged; D009765:Obesity / Q000652:urine*; D011379:Prognosis; D013959:Thyroid Diseases / Q000652:urine*
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000728:Androgens; D005938:Glucocorticoids; D003687:Dehydroepiandrosterone; D005043:Etiocholanolone; D000738:Androsterone